Detalles de la búsqueda
1.
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma.
Pathologica
; 116(1): 55-61, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38482675
2.
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma.
N Engl J Med
; 383(13): 1218-1230, 2020 09 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32945632
3.
Nectin-4 and DNA mismatch repair proteins expression in upper urinary tract urothelial carcinoma (UTUC) as a model for tumor targeting approaches: an ImGO pilot study.
BMC Cancer
; 22(1): 168, 2022 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35164713
4.
Analysis by region of outcomes for patients with advanced renal cell carcinoma treated with cabozantinib or everolimus: a sub-analysis of the METEOR study.
Acta Oncol
; 61(1): 52-57, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34736367
5.
Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer.
Future Oncol
; 18(19): 2361-2371, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35416053
6.
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?
Curr Oncol Rep
; 23(12): 147, 2021 11 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34748099
7.
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme.
BJU Int
; 123(1): 98-105, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29956884
8.
Docetaxel rechallenge in metastatic castration-resistant prostate cancer: any place in the modern treatment scenario? An intention to treat evaluation.
Future Oncol
; 11(22): 3083-90, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26437324
9.
Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up.
J Clin Oncol
; 41(19): 3486-3492, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37071838
10.
Patient-reported Outcomes from JAVELIN Bladder 100: Avelumab First-line Maintenance Plus Best Supportive Care Versus Best Supportive Care Alone for Advanced Urothelial Carcinoma.
Eur Urol
; 83(4): 320-328, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35654659
11.
Avelumab First-line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the JAVELIN Bladder 100 Phase 3 Trial.
Eur Urol
; 84(1): 95-108, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37121850
12.
Safety of First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC: A Pooled Analysis of CheckMate 227, CheckMate 568, and CheckMate 817.
J Thorac Oncol
; 18(1): 79-92, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36049658
13.
Targeted Approaches in Metastatic Castration-Resistant Prostate Cancer: Which Data?
Cancers (Basel)
; 14(17)2022 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36077726
14.
Looking for a Simplified Diagnostic Model to Identify Potentially Lethal Cases of Prostate Cancer at Initial Diagnosis: An ImGO Pilot Study.
Cancers (Basel)
; 14(6)2022 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35326693
15.
Primary Tumor Shrinkage and the Effect on Metastatic Disease and Outcomes in Patients With Advanced Kidney Cancer With Intermediate or Poor Prognosis Treated With Nivolumab Plus Ipilimumab or Cabozantinib.
Clin Genitourin Cancer
; 20(5): 498.e1-498.e9, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35768316
16.
First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial.
J Thorac Oncol
; 17(2): 289-308, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34648948
17.
Treatment of recurrent glioblastoma with stereotactic radiotherapy: long-term results of a mono-institutional trial.
Tumori
; 97(1): 56-61, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21528665
18.
Depatuxizumab Mafodotin (Depatux-M) Plus Temozolomide in Recurrent Glioblastoma Patients: Real-World Experience from a Multicenter Study of Italian Association of Neuro-Oncology (AINO).
Cancers (Basel)
; 13(11)2021 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34204877
19.
First-line pazopanib in patients with advanced non-clear cell renal carcinoma: An Italian case series.
World J Clin Oncol
; 12(11): 1037-1046, 2021 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34909398
20.
Correlation Between Immune-related Adverse Event (IRAE) Occurrence and Clinical Outcome in Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Nivolumab: IRAENE Trial, an Italian Multi-institutional Retrospective Study.
Clin Genitourin Cancer
; 18(6): 477-488, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32732112